110 related articles for article (PubMed ID: 24553582)
1. Colestimide improves glycemic control via hepatic glucose production in db/db mice.
Yamakawa T; Ogihara K; Utsunomiya H; Muraoka T; Kadonosono K; Terauchi Y
Endocr J; 2014; 61(5):425-36. PubMed ID: 24553582
[TBL] [Abstract][Full Text] [Related]
2. Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin.
Kobayashi M; Ikegami H; Fujisawa T; Nojima K; Kawabata Y; Noso S; Babaya N; Itoi-Babaya M; Yamaji K; Hiromine Y; Shibata M; Ogihara T
Diabetes; 2007 Jan; 56(1):239-47. PubMed ID: 17192488
[TBL] [Abstract][Full Text] [Related]
3. What characteristics at baseline are associated with the glucose-lowering effect of colestimide in patients with type 2 diabetes and hypercholesterolemia according to response to treatment?
Suzuki T; Tsunoda-Kubota M; Aoyama J; Futami-Suda S; Hashimoto M; Igari Y; Watanabe K; Kigawa Y; Nakano H; Oba K
J Nippon Med Sch; 2013; 80(3):211-7. PubMed ID: 23832405
[TBL] [Abstract][Full Text] [Related]
4. Effect of colestimide therapy for glycemic control in type 2 diabetes mellitus with hypercholesterolemia.
Yamakawa T; Takano T; Utsunomiya H; Kadonosono K; Okamura A
Endocr J; 2007 Feb; 54(1):53-8. PubMed ID: 17102570
[TBL] [Abstract][Full Text] [Related]
5. Glucose-lowering effect of colestimide is associated with baseline HbA1c in type 2 diabetic patients with hypercholesterolemia.
Yamakawa T; Kaneko T; Shigematu E; Kawaguchi J; Kadonosono K; Morita S; Terauchi Y
Endocr J; 2011; 58(3):185-91. PubMed ID: 21350303
[TBL] [Abstract][Full Text] [Related]
6. Hypoglycemic effects of colestimide on type 2 diabetic patients with obesity.
Neda T; Inukai K; Kurihara S; Ono H; Hosaka T; Nakamoto H; Katayama S; Awata T
Endocr J; 2012; 59(3):239-46. PubMed ID: 22230809
[TBL] [Abstract][Full Text] [Related]
7. Blood glucose-lowering activity of colestimide in patients with type 2 diabetes and hypercholesterolemia: a case-control study comparing colestimide with acarbose.
Suzuki T; Oba K; Futami S; Suzuki K; Ouchi M; Igari Y; Matsumura N; Watanabe K; Kigawa Y; Nakano H
J Nippon Med Sch; 2006 Oct; 73(5):277-84. PubMed ID: 17106179
[TBL] [Abstract][Full Text] [Related]
8. Effects of bile-acid-binding resin (colestimide) on blood glucose and visceral fat in Japanese patients with type 2 diabetes mellitus and hypercholesterolemia: an open-label, randomized, case-control, crossover study.
Suzuki T; Oba K; Igari Y; Watanabe K; Matsumura N; Futami-Suda S; Ouchi M; Suzuki K; Sekimizu K; Kigawa Y; Nakano H
J Diabetes Complications; 2012; 26(1):34-9. PubMed ID: 22240263
[TBL] [Abstract][Full Text] [Related]
9. Comparison of efficacy of pitavastatin and colestimide in Japanese patients with diabetes mellitus complicated by hyperlipidemia and metabolic syndrome.
Kato T; Inagaki K; Sawai Y; Kanayama H; Katada N; Itoh M
Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):554-8. PubMed ID: 21472664
[TBL] [Abstract][Full Text] [Related]
10. Oleanolic acid improves hepatic insulin resistance via antioxidant, hypolipidemic and anti-inflammatory effects.
Wang X; Liu R; Zhang W; Zhang X; Liao N; Wang Z; Li W; Qin X; Hai C
Mol Cell Endocrinol; 2013 Aug; 376(1-2):70-80. PubMed ID: 23791844
[TBL] [Abstract][Full Text] [Related]
11. [A case of type 2 diabetes mellitus associated with familial hypercholesterolemia confirming the improvement of blood glucose control by colestimide].
Takahashi S; Zenimaru Y; Suzuki J; Miyamori I
Nihon Ronen Igakkai Zasshi; 2009; 46(6):545-50. PubMed ID: 20139652
[TBL] [Abstract][Full Text] [Related]
12. Effects of rosuvastatin and colestimide on metabolic parameters and urinary monocyte chemoattractant protein-1 in type 2 diabetic patients with hyperlipidemia.
Takebayashi K; Suetsugu M; Matsumoto S; Aso Y; Inukai T
South Med J; 2009 Apr; 102(4):361-8. PubMed ID: 19279518
[TBL] [Abstract][Full Text] [Related]
13. Effects of colestimide on blood glucose-lowering activity and body weight in patients with type 2 diabetes and hypercholesterolemia.
Suzuki T; Oba K; Futami-Suda S; Suzuki K; Ouchi M; Igari Y; Matsumura N; Watanabe K; Kigawa Y; Nakano H
J Nippon Med Sch; 2007 Feb; 74(1):81-4. PubMed ID: 17384485
[No Abstract] [Full Text] [Related]
14. The caffeoylquinic acid-rich Pandanus tectorius fruit extract increases insulin sensitivity and regulates hepatic glucose and lipid metabolism in diabetic db/db mice.
Wu C; Zhang X; Zhang X; Luan H; Sun G; Sun X; Wang X; Guo P; Xu X
J Nutr Biochem; 2014 Apr; 25(4):412-9. PubMed ID: 24629909
[TBL] [Abstract][Full Text] [Related]
15. Methazolamide is a new hepatic insulin sensitizer that lowers blood glucose in vivo.
Konstantopoulos N; Molero JC; McGee SL; Spolding B; Connor T; de Vries M; Wanyonyi S; Fahey R; Morrison S; Swinton C; Jones S; Cooper A; Garcia-Guerra L; Foletta VC; Krippner G; Andrikopoulos S; Walder KR
Diabetes; 2012 Aug; 61(8):2146-54. PubMed ID: 22586591
[TBL] [Abstract][Full Text] [Related]
16. Effect of magnesium sulfate administration to improve insulin resistance in type 2 diabetes animal model: using the hyperinsulinemic-euglycemic clamp technique.
Sohrabipour S; Sharifi MR; Sharifi M; Talebi A; Soltani N
Fundam Clin Pharmacol; 2018 Dec; 32(6):603-616. PubMed ID: 29869808
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of MEK1 Signaling Pathway in the Liver Ameliorates Insulin Resistance.
Ueyama A; Ban N; Fukazawa M; Hirayama T; Takeda M; Yata T; Muramatsu H; Hoshino M; Yamamoto M; Matsuo M; Kawashima Y; Iwase T; Kitazawa T; Kushima Y; Yamada Y; Kawabe Y
J Diabetes Res; 2016; 2016():8264830. PubMed ID: 26839898
[TBL] [Abstract][Full Text] [Related]
18. Treatment with exendin-4 improves the antidiabetic efficacy and reverses hepatic steatosis in glucokinase activator treated db/db mice.
Dhanesha N; Joharapurkar A; Shah G; Kshirsagar S; Patel V; Patel K; Bahekar R; Jain M
Eur J Pharmacol; 2013 Aug; 714(1-3):188-92. PubMed ID: 23810686
[TBL] [Abstract][Full Text] [Related]
19. Nardostachys jatamansi DC Extract Alleviates Insulin Resistance and Regulates Glucose Metabolism in C57BL/KsJ-db/db Mice Through the AMP-Activated Protein Kinase Signaling Pathway.
You HN; Park MH; Hwang SY; Han JS
J Med Food; 2018 Apr; 21(4):324-331. PubMed ID: 29630449
[TBL] [Abstract][Full Text] [Related]
20. Comparison of sevelamer hydrochloride with colestimide, administered alone or in combination with calcium carbonate, in patients on hemodialysis.
Itoh K; Tanaka M; Hashiguchi J; Funakoshi S; Nakano H; Kubo H; Kono T; Uchino J; Masaki K; Date T; Shigematsu T;
Ther Apher Dial; 2008 Apr; 12(2):126-32. PubMed ID: 18387160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
